Trials and Noteworthy Treatments

			Treatment Next 25		Location		Last Updated
	Details		A Phase I Study of Peptide Vaccination With Tumor Associated Antigens Mixed With Montanide ISA-51VG in Pediatric Patients With Recurrent or Refractory Central Nervous System Tumors		New York, NY		03/10/2011
	Details		Molecular Biology of Central Nervous System (CNS) Tumors		Houston, TX		12/20/2010
	Details		A Phase I Trial and Pharmacokinetic Study of Trabectedin (Yondelis®, ET-743) in Children and Adolescents With Relapsed or Refractory Solid Tumors		Bethesda, MD		04/22/2009
	Details		A Phase I/II Trial of ZD6474 for Patients With Recurrent High-Grade and Progressive Low-Grade Gliomas		Bethesda, MD		04/22/2009
	Details		Multiple Ascending Dose (MAD) Study of the IGF-1R Antagonist R1507 Administered as an Intravenous Infusion in Pediatric Patients With Advanced Solid Tumors.		Bethesda, MD		04/22/2009
	Details		Quality of Life in Patients with Brain Tumors, Skull Base Tumors & Pituitary Adenomas Undergoing Surgical Resection		Santa Monica, CA		11/29/2008
	Details		Bevacizumab (Avastin) and Irinotecan (CPT-11) in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma		San Francisco, CA Washington, DC Chicago, IL Boston, MA Bethesda, MD Durham, NC Philadelphia, PA Pittsburgh, PA Memphis, TN Seattle, WA		11/08/2008
	Details		A Phase 1/11 Study of Topotecan by Intracerebral Clysis for the Treatment of Recurrent Primary Malignant Brain Tumors		NEW YORK CITY, NY		08/20/2007
	Details		Phase II Study of Intrathecal I-3F8 in Patients With GD2-Expressing Central Nervous System and Leptomeningeal Neoplasms		New York, NY		08/20/2007
	Details		Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor		Perth, Western Australia, 6001, Australia Hamilton, Canada Orange, CA Sacramento, CA Washington, DC St. Petersburg, FL West Palm Beach, FL Atlanta, GA Indianapolis, IN Kansas City, MO Charlotte, NC Paterson, NJ Summit, NJ New York, NY Columbus, OH Oklahoma City, OK Pittsburgh, PA San Antonio, TX Roanoke, VA Charleston, WV		08/18/2007
	Details		Phase II Trial of Tumor Lysate-Pulsed Dendritic Cell Immunotherapy for Patients with Atypical or Malignant, Primary or Metastatic Brain Tumors of the Central Nervous System		Los Angeles, CA		08/18/2007
	Details		Brain Mapping for Brain Tumors		Boston, MA		08/18/2007
	Details		Pilot Randomized Study of Modafinil for Treatment of Fatigue and Neurobehavioral Dysfunction in Patients With Primary Brain Tumors		Los Angeles, CA		05/29/2006
	Details		Phase 3 study: Radiation Therapy and Combination Chemotherapy Followed by Autologous Stem Cell Transplant in Treating Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor		Durham, NC Memphis, TN Houston, TX		05/02/2006
	Details		"Head Start" chemotherapy protocol for children less than 10 years old with newly diagnosed high grade primary brain tumors with intent to eliminate irradiation and abbreviate total duration of treatment to 6 months with resultant improved cure rate and quality of survival.		Oakland, CA		05/01/2006
	Details		Headstart II A Phase II study of two alternative intensive induction chemotherapy followed by consolidation with myeloablative chemotherapy and autologous stem cell rescue with or without subsequent radiation therapy for children less than 10 yrs of age newly diagnosed with malignant brain tumors		Oakland, CA		05/01/2006
	Details		Pharmacological intervention for learning impaired children surviving treatment for cancer.		Durham, NC		12/03/2005
	Details		Gamma Knife Radiosurgery		Smithtown, NY		12/03/2005
	Details		Gamma Knife Radiosurgery for Brain Tumors		La Jolla, CA		12/03/2005
	Details		Phase I trial of Temozolomide (Temodar) and O6-Benzylguanine (o6-bg)in pediatric patients with recurrent brain tumors.		Durham, NC		12/03/2005
	Details		A Phase I dose escalation trial of Temodar that will attempt to determine the maximum tolerated dose of Temodar (Temozolomide) when given by prolonged oral exposure to children with recurrent or progressive brain tumors.		New York, NY		12/03/2005
	Details		Gamma Knife Radiosurgery		Edison, NJ		12/03/2005
	Details		Gamma knife stereotactic radiosurgery for benign and malignant brain tumors and brain metastases.		Rockville Centre, NY		12/03/2005
	Details		Quality of Life Studies (There are 19 seperate studies listed here)		Durham, NC		12/03/2005
	Details		Treatment of newly diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor (PNET), or Atypical Teratoid Rhabdoid Tumor (ATRT)		Memphis, TN		12/03/2005

News Stories

(Relevance) Question - click to see the response!
Displaying 1 to 21 of 21
Click HERE for Next 25 articles!

(Relevance) Page Title - click title to go to the page!

•   (0.8658)   Improving Treatment of Medulloblastoma, a Common Childhood Brain Tumor;
  
  
•   (0.8510)   Reovirus Prolongs Survival and Reduces the Frequency of Spinal and Leptomeningeal Metastases from Medulloblastoma
  
  
•   (0.8351)   Technique Could Speed New Medulloblastoma Drugs
  
  
•   (0.8351)   Post-Therapy Damage Seen on MRI Scans of Medulloblastoma Patients Can Be Mistaken for New Tumors
  
  
•   (0.8351)   Results of a Randomized Study of Preradiation Chemotherapy Versus Radiotherapy Alone for Nonmetastatic Medulloblastoma: The International Society of Paediatric Oncology/United Kingdom Children`s Cancer Study Group PNET-3 Study.
  
  
•   (0.8169)   Autumn Birth Linked to Childhood Brain Cancer
  
  
•   (0.8169)   Clinical, Histopathologic, and Molecular Markers of Prognosis: Toward a New Disease Risk Stratification System for Medulloblastoma.
  
  
•   (0.8169)   A flower that causes birth defects in grazing sheep has offered valuable clues about treating brain tumors in children, researchers said on Thursday. [Applies to Medulloblastoma]
  
  
•   (0.8169)   New Treatment Likely to Increase Survival Rates in Patients with Medulloblastoma -- a Rare Pediatric Brain Tumor (PR Newswire)
  An ongoing study at St. Jude Children`s Research Hospital indicates that a new treatment protocol could increase survival rates for some pediatric brain cancers to 80 percent for high-risk and 90 percent for standard-risk.
  - May 11 7:30 AM ET
  
  
•   (0.7967)   Curis, Roche drug combats children`s brain tumors (Medulloblastoma)
  
  
•   (0.7967)   The Samantha Dickson Research Trust has become the largest funder of laboratory based brain tumour research in the UK, and offers a vital support link for brain tumour patients and their families or carers.
  
  
•   (0.7967)   Autumn Birth Linked to Childhood Brain Cancer
  
  
•   (0.7967)   Health Highlights: Feb. 20, 2002 (HealthSCOUT)
  ...About 75 percent of patients with the hard-to-treat form of cancer saw their tumors shrink after a single dose of the drug, the Associated Press reports.......-- Some Brain Tumors May Be Linked to Virus A common virus that usually lies dormant in as many as 70 percent...... in as many as 70 percent of all children may be responsible for a particular type of brain tumor, BBC News Online reports.......Medulloblastoma is the most common type of cancer to afflict the brains of children, the report says. Researchers from Temple University found that children suffering...
  - Feb 20 11:55 PM ET
  
  
•   (0.7742)   IBTA E News February 2011
  
  
•   (0.7742)   IBTA E-News July 2010
  
  
•   (0.7742)   Prenatal Vitamins May Fend Off Some Childhood Brain Tumors
  
  
•   (0.7742)   Functional VEGF and VEGF receptors are expressed in human medulloblastomas
  
  
•   (0.7742)   Young Girl Fighting For Her Life (KGTV TheSanDiegoChannel.com)
  ...-- a cancer that causes tumors in the brain and spinal column -...
  - Jan 22 8:56 PM ET
  
  
•   (0.7742)   Insight Into Brain Tumor Spread May Aid Treatment (Reuters)
  Researchers have identified the underlying genetic regulation of an invasive type of brain tumor called medulloblastoma--a finding they say could lead to new strategies to prevent the spread of this tumor.
  - Sep 03 7:42 PM ET
  
  
•   (0.7742)   New gene target found for common brain tumors in children
  
  
•   (0.7742)   Extraneural metastases of paediatric brain tumours
  
  

Frequently Asked Questions

(Relevance) Question - click to see the response!
Displaying 1 to 3 of 3